相关实验视频
Updated: Jul 16, 2025

07:58
Tricolor Transgenic Murine Model for Studying Growth Plate Injury
Published on: September 6, 2024
654
投射新的光线:治疗形细胞和生长障碍的新疗法
Nadia Merchant1, Andrew Dauber1
1Division of Endocrinology, Children's National Hospital, Washington, DC 20010, USA; Department of Pediatrics, George Washington University School of Medicine and Health Sciences, Washington, DC 20037, USA.
Pediatric clinics of North America
|September 13, 2023
概括
严重矮身的常见原因之一 - - 骨髓质变化症 (Achondroplasia) 正在出现针对生长板发育的新型疾病修饰药物. 这些创新疗法旨在改善冠状细胞生长,为患者提供新的希望.
科学领域:
- 遗传学和分子生物学
- 儿科内分泌学 儿科内分泌学
- 骨发育不良症 骨发育不良症
背景情况:
- 无粒细胞增生是严重不成比例的矮身的主要原因.
- 目前的管理重点是医疗和心理社会问题的症状治疗.
- 了解阿德罗普拉西亚的遗传和分子基础的进步刺激了新的治疗开发.
研究的目的:
- 审查疾病修饰药物的新兴景观,以治疗无形质变化症.
- 突出针对生长板的治疗策略,以刺激淋巴细胞.
- 为开发中的新药候选药物提供概述.
主要方法:
- 审查当前的科学文献关于无形质形成症.
- 新型治疗剂的识别和分类.
- 药物点和作用机制的总结.
主要成果:
- 几种新型药物类型正在为阿德罗普拉西亚进行研究.
- 这些疗法向生长板,以增强冠状细胞的生长和发育.
- 例如包括C型尿性 (CNP) 类型,FGFR3抑制剂,抗FGFR3抗体和FGF2体.
结论:
- 针对生长板的新型疾病修饰药物正在出现,用于阿德罗普拉西亚.
- 这些疗法代表了从纯粹的症状管理到显著的转变.
- 长期疗效和对医学并发症的影响需要进一步研究.
相关概念视频
Gene Therapy
25.5K
Gene therapy is a technique where a gene is inserted into a person’s cells to prevent or treat a serious disease. The added gene may be a healthy version of the gene that is mutated in the patient, or it could be a different gene that inactivates or compensates for the patient’s disease-causing gene. For example, in patients with severe combined immunodeficiency (SCID) due to a mutation in the gene for the enzyme adenosine deaminase, a functioning version of the gene can be...
25.5K
Nature and Nurture
20.5K
Many human characteristics, like height, are shaped by both nature—in other words, by our genes—and by nurture, or our environment. For example, chronic stress during childhood inhibits the production of growth hormones and consequently reduces bone growth and height. Scientists estimate that 70-90% of variation in height is due to genetic differences among individuals, and 10-30% of variation in height is due to differences in the environments that individuals experience,...
20.5K
Growth of Cartilage and Bone Tissue
3.4K
Chondrocytes form a temporary cartilaginous model by dividing and secreting a thick gel-like extracellular matrix. Once the chondrocytes undergo programmed cell death, osteoblasts enter the site of the cartilaginous model. The process of replacing the temporary cartilaginous model with bone in an ordered manner is called endochondral ossification. In endochondral ossification, not all of the cartilage is replaced by bone tissue. Some cartilage that performs a protective and supportive function...
3.4K
Hormones and Bone Tissue
2.7K
The endocrine system produces and secretes hormones, which interact with the skeletal system. These hormones control bone growth, maintain bone once it is formed, and remodel it.
Hormones That Influence Osteoblasts and/or Maintain the Matrix
Several hormones are necessary for controlling bone growth and maintaining the bone matrix. The pituitary gland secretes growth hormone (GH), which, as its name implies, controls bone growth. This happens in several ways: first, it triggers chondrocyte...
Hormones That Influence Osteoblasts and/or Maintain the Matrix
Several hormones are necessary for controlling bone growth and maintaining the bone matrix. The pituitary gland secretes growth hormone (GH), which, as its name implies, controls bone growth. This happens in several ways: first, it triggers chondrocyte...
2.7K
Role of Hematopoietic Growth Factors
1.4K
Hematopoietic growth factors are molecules that regulate the differentiation rate of hematopoietic stem cells (HSCs). Erythropoietin (EPO), primarily produced by the kidneys, plays a crucial role in erythrocyte production. When oxygen levels in the blood are low, EPO is released into the bloodstream, reaching the bone marrow, where it stimulates HSCs to differentiate and mature into erythrocytes, which are vital for oxygen transport.
Thrombopoietin (TPO), mainly released by the liver,...
Thrombopoietin (TPO), mainly released by the liver,...
1.4K
Targeted Cancer Therapies
7.7K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.7K

